NCT00162760View on ClinicalTrials.gov

Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

July 31, 2007

Conditions
Idiopathic Pulmonary Fibrosis (IPF)
Interventions
DRUG

Thalidomide

Trial Locations (1)

21287

Johns Hopkins School of Medicine, Baltimore

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

Johns Hopkins University

OTHER